Pharmaron Acquires Land in Beijing BDA to Build New R&D Campus -
Saturday, May 16, 2009
Pharmaron announced today that it has acquired Lot X27F1, located in the southern part of Beijing BDA, to build its own state-of-the-art R&D campus. Phase I construction of the 1.1 million square feet R&D facility will begin in October.
“Just over 4 years ago, Pharmaron had 100 scientists,” commented Mr. Xiao Qiang Lou, COO of Pharmaron-Beijing. “With revenues having doubled every year since then, our current laboratory capacity will not meet our continued future growth. The new R&D campus will enable us to deliver integrated drug discovery services to our current clients and allow us to expand as our customer’s needs grow.”